Bio Xcel LLC is > 10% Shareholder of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 8.55 Million shares of BTAI, which is worth approximately $5.73 Million. The most recent transaction as insider was on Jun 25, 2021, when has been sold 473,250 shares (Common Stock) at a price of $30.83 per share, resulting in proceeds of $14,590,297. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.55M
0% 3M change
0% 12M change
Total Value Held $5.73 Million

BioXcel LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2021
SELL
Open market or private sale
$14,590,297 $30.83 p/Share
473,250 Reduced 5.25%
8,546,750 Common Stock
Jul 24 2020
SELL
Other acquisition or disposition
$9,721,600 $60.76 p/Share
160,000 Reduced 1.74%
9,020,000 Common Stock
BL

Bio Xcel LLC

> 10% Shareholder
Guilford, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Track Activities on BTAI